Evidence map›Paper›PMID 14557619›Full record

ArticleJournal of virology2003

Measles virus (MV) nucleoprotein binds to a novel cell surface receptor distinct from FcgammaRII via its C-terminal domain: role in MV-induced immunosuppression.

David Laine, Marie-Claude Trescol-Biémont, Sonia Longhi, Geneviève Libeau, Julien C Marie, Pierre-Olivier Vidalain, Olga Azocar, Adama Diallo, Bruno Canard, Chantal Rabourdin-Combe and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Cell surface nucleocapsid protein expression: A betacoronavirus immunomodulatory strategy.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Modulation of Measles Virus NBiomolecules · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

David LaineLaboratoire d'Immunobiologie Fondamentale et Clinique, INSERM U503, IFR128 BioSciences Lyon-Gerland, 69365 Lyon Cedex 07, France.
Marie-Claude Trescol-Biémont
Sonia Longhi
Geneviève Libeau
Julien C Marie
Pierre-Olivier Vidalain
Olga Azocar
Adama Diallo
Bruno Canard
Chantal Rabourdin-Combe
Hélène Valentin
Inserm · FRArchitecture et Fonction des Macromolécules Biologiques · FRCentre de Coopération Internationale en Recherche Agronomique pour le Développement · FRFAO/IAEA Agriculture and Biotechnology Laboratories · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During acute measles virus (MV) infection, an efficient immune response occurs, followed by a transient but profound immunosuppression. MV nucleoprotein (MV-N) has been reported to induce both cellular and humoral immune responses and paradoxically to account for immunosuppression. Thus far, this latter activity has been attributed to MV-N binding to human and murine FcgammaRII. Here, we show that apoptosis of MV-infected human thymic epithelial cells (TEC) allows the release of MV-N in the extracellular compartment. This extracellular N is then able to bind either to MV-infected or uninfected TEC. We show that recombinant MV-N specifically binds to a membrane protein receptor, different from FcgammaRII, highly expressed on the cell surface of TEC. This new receptor is referred to as nucleoprotein receptor (NR). In addition, different Ns from other MV-related morbilliviruses can also bind to FcgammaRII and/or NR. We show that the region of MV-N responsible for binding to NR maps to the C-terminal fragment (N(TAIL)). Binding of MV-N to NR on TEC triggers sustained calcium influx and inhibits spontaneous cell proliferation by arresting cells in the G(0) and G(1) phases of the cell cycle. Finally, MV-N binds to both constitutively expressed NR on a large spectrum of cells from different species and to human activated T cells, leading to suppression of their proliferation. These results provide evidence that MV-N, after release in the extracellular compartment, binds to NR and thereby plays a role in MV-induced immunosuppression.

Indexed as

Immune ToleranceAnimalsApoptosisCell LineEpithelial CellsHumansLymphocyte ActivationMeasles virusMiceNucleocapsid ProteinsNucleoproteinsReceptors, Cell SurfaceReceptors, IgGRecombinant ProteinsThymus GlandT-LymphocytesNucleocapsid Proteinsnucleoprotein, Measles virusNucleoproteinsReceptors, Cell SurfaceReceptors, IgGRecombinant ProteinsViral Proteins

Identifiers

PMID14557619
PMCPMC229257
OpenAlexW2122101032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.